Patents by Inventor Steven Marso

Steven Marso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
    Patent number: 8133866
    Abstract: This invention provides for a method for inhibiting new tissue growth in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit new tissue growth in the subject's blood vessels. The invention also provides for method for inhibiting neointimal formation in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit neointimal formation in the subject's blood vessels.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: March 13, 2012
    Assignees: The Trustees of Columbia University in the City of New York, The Cleveland Clinic Foundation
    Inventors: David M. Stern, Ann Marie Schmidt, Steven Marso, Eric Topol, A. Michael Lincoff
  • Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
    Publication number: 20100292134
    Abstract: This invention provides for a method for inhibiting new tissue growth in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit new tissue growth in the subject's blood vessels. The invention also provides for method for inhibiting neointimal formation in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit neointimal formation in the subject's blood vessels.
    Type: Application
    Filed: June 7, 2010
    Publication date: November 18, 2010
    Inventors: David M. Stern, Ann Marie Schmidt, Steven Marso, Eric Topol, A. Michael Lincoff
  • Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
    Patent number: 7732400
    Abstract: This invention provides for a method for inhibiting new tissue growth in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit new tissue growth in the subject's blood vessels. The invention also provides for method for inhibiting neointimal formation in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit neointimal formation in the subject's blood vessels.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: June 8, 2010
    Assignees: The Trustees of Columbia University in the City of New York, The Cleveland Clinic Foundation
    Inventors: David M. Stern, Ann Marie Schmidt, Steven Marso, Eric Topol, A. Michael Lincoff
  • Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
    Publication number: 20080171701
    Abstract: This invention provides for a method for inhibiting new tissue growth in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit new tissue growth in the subject's blood vessels. The invention also provides for method for inhibiting neointimal formation in blood vessels in a subject, wherein the subject experienced blood vessel injury, which comprises administering to the subject a pharmaceutically effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE) so as to inhibit neointimal formation in the subject's blood vessels.
    Type: Application
    Filed: August 20, 2007
    Publication date: July 17, 2008
    Inventors: David M. Stern, Ann Marie Schmidt, Steven Marso, Eric Topol, A. Michael Lincoff